uridine triphosphate has been researched along with Leukemia, Erythroblastic, Acute in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gardell, SJ; Shi, XP; Yin, KC | 1 |
| Baltensperger, K; Porzig, H | 1 |
| Schultz, G; Schwaner, I; Seifert, R | 1 |
3 other study(ies) available for uridine triphosphate and Leukemia, Erythroblastic, Acute
| Article | Year |
|---|---|
Human erythroleukemic (HEL) cells express a platelet P2T-like ADP receptor.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Biological Transport; Blood Platelets; Calcium; Humans; Leukemia, Erythroblastic, Acute; Megakaryocytes; Neoplasm Proteins; Neoplastic Stem Cells; Platelet Activation; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Thionucleotides; Tumor Cells, Cultured; Uridine Triphosphate | 1995 |
The P2U purinoceptor obligatorily engages the heterotrimeric G protein G16 to mobilize intracellular Ca2+ in human erythroleukemia cells.
Topics: Adenosine Triphosphate; Calcium; Enzyme Inhibitors; GTP-Binding Proteins; Hematopoietic Stem Cells; Humans; Leukemia, Erythroblastic, Acute; Receptors, Purinergic P2; Receptors, Purinergic P2Y2; RNA, Antisense; Signal Transduction; Thapsigargin; Tumor Cells, Cultured; Uridine Triphosphate | 1997 |
Receptor-mediated increases in cytosolic Ca2+ in the human erythroleukaemia cell line involve pertussis toxin-sensitive and -insensitive pathways.
Topics: Adenosine Triphosphate; Calcium; Cytosol; Epoprostenol; Humans; Leukemia, Erythroblastic, Acute; Pertussis Toxin; Platelet Activating Factor; Prostaglandins E; Receptors, Cell Surface; Signal Transduction; Thrombin; Tumor Cells, Cultured; Uridine Triphosphate; Virulence Factors, Bordetella | 1992 |